Tag Archives: dolutegravir

Drug-resistance or viral load testing required before switch to dolutegravir in Togo

Dolutegravir-based antiretroviral treatment (ART) in combination with an NRTI backbone will not be effective in Togo, due to high levels of resistance to the NRTI class of drugs, according to a study presented by Professor Mounerou Salou of the Laboratoire Biolim in Togo at the recent 20th International Conference on AIDS and STIs in Africa (ICASA)… Read More »

ADVANCE study shows high frequency of major weight gain in women receiving dolutegravir with TAF

Metabolic syndrome – including obesity – developed significantly more frequently in people who received dolutegravir, tenofovir alafenamide (TAF) and emtricitabine compared to other regimens in the South African ADVANCE study, Michelle Moorhouse reported on Thursday at the 17th European AIDS Conference in Basel, Switzerland. Furthermore, updated follow-up from the study showed that close to 60%… Read More »